U.S. FDA Bests EMA in Cancer Drug Approval Times, Study Finds
The U.S. Food and Drug Administration (FDA) continues to approve cancer drugs more quickly than the European Medicines Agency (EMA), clearing them in about half the time regardless of the drug’s designation, according to a recent study.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.